Gm2 Gangliosidoses Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | D | iShares Neuroscience and Healthcare ETF | 0.61 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 0.43 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.41 | |
IWC | C | iShares Microcap ETF | 0.09 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 0.04 |
Compare ETFs
Related Industries:
Biotechnology
- Gm2 Gangliosidoses
Gm2 Gangliosidoses is a group of rare, inherited disorders caused by the buildup of a fatty substance called GM2 ganglioside in the body's cells. This buildup can cause a wide range of symptoms, including intellectual disability, seizures, movement problems, and vision and hearing loss. Treatment is supportive and may include physical, occupational, and speech therapy, as well as medications to control seizures.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles